Safety Dutasteride for Women / Men Hair Loss Treatment Powder CAS 164656-23-9
2016-09-13 07:15  Views:234
Price:0.00 USD/-
Brand:-
Model:-
MOQ:-0 -
Send Inquiry

 

 

Safety Dutasteride for Women / Men Hair Loss Treatment Powder CAS 164656-23-9

 

 

Quick Detail:

 

Product name Dutasteride Factory Supplying
Other name DUTASTERIDE; Duagen; Avodart
CAS register number 164656-23-9
Molecular formula C27H30F6N2O2
Molecular weight 528.53
Molecular structure
Melting point 242°C~250°C
Assay 99%

 

 

 

 

Product description:


Dutasteride (trademark name Avodart) is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Used for benign prostatic hyperplasia; however, it increases the risk of erectile dysfunction and decreased sexual desire.

Dutasteride useful for the symptoms of benign prostatic hyperplasia (BPH); colloquially known as an "enlarged prostate".

In those who are being regularly screened 5-alpha-reductase inhibitor (finasteride and dutasteride) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they have an effect on the risk of death and may increase the chance of more serious cases.

This class of medications increases rates of erectile dysfunction (with between 5% and 9% developing problems after starting their use). This is linked to lower quality of life and can cause stress in relationships. There is also an association with lowered sexual desire. It has been reported that these adverse sexual side effects may persist even after discontinuation of the drug.

The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer. While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer. The primary area for concern is for patients who may develop prostate cancer whilst taking dutasteride for benign prostatic hyperplasia, which in turn could delay diagnosis and early treatment of the prostate cancer, thereby potentially increasing the risk of these patients developing high-grade prostate cancer.

 

 

 

 

 

 

Specification:


COA:

 

Product name Dutasteride
Appearance White crystalline powder
Assay(*) 98101.0% 99.4%
Identification By UV, To match with working standard Complies
Related Substances Not more than the reference solution (0.05%) Complies
Heavy metals ≤10ppm 9ppm
Contact Infomation
Send Inquiry
Company name:China Chemical Products Market
Status:[Offline] [Send message] [Chat]
Business contact:Willi (Ms.)
Telphone:
Mobile:
Fax:
Area: Caribbean Region-Bermuda
Address:1111,Fuli Inxcvc, West Hzxzcz Rd
Zip:510000